About Amylin Pharmaceuticals, Inc

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. As of December 31, 2008, the Company was marketing two medicines to treat diabetes: BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. – more... 

Reviews

Overall

4.4
Based on 10 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
Compensation/Benefits
Job Security/Advancement
Management
Culture

Salaries

Claim this company page
Headquarters
San Diego California, United States
Revenue
$758.4 Million
Employees
1,001 to 5,000
Industry
Links
Amylin Pharmaceuticals, Inc website